SCHEMBL18092247

SCHEMBL18092247

CN(C)CCCN(C)c1ncccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.42
CYP2D6 P10635 2/20 0.42
SYK P43405 1/20 0.40
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
ALOX15 P16050 1/20 0.37
CHRM2 P08172 2/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SCN1A P35498 1/20 0.37
SCN2A Q99250 1/20 0.37
SCN3A Q9NY46 1/20 0.37
HTR2A P28223 2/20 0.36
HRH1 P35367 2/20 0.36
SIGMAR1 Q99720 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
LSS P48449 1/20 0.36
ADRA2A P08913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12889037 0.82 PTPN11 (0.40) CYP2C19CYP2D6ALDH1A1TSHRMAPT
SCHEMBL934070 0.81 ALDH1A1 (0.33) CYP2C19CYP2D6SYKALDH1A1TSHR
SCHEMBL23405906 0.80 FLT3 (0.42) CYP2C19CYP2D6SYKLMNAMAPT
SCHEMBL29743979 0.80 FLT3 (0.42) CYP2C19CYP2D6SYKLMNAMAPT
SCHEMBL9272657 0.76 KCNA5 (0.42) CYP2C19CYP2D6KCNH2
SCHEMBL6158014 0.74 POLB (0.52) CYP2C19CYP2D6ALDH1A1MAPTKDM4E
SCHEMBL29744072 0.73 F12 (0.44) CYP2C19CYP2D6SYKLMNAMAPT
SCHEMBL23405914 0.73 F12 (0.44) CYP2C19CYP2D6SYKLMNAMAPT
SCHEMBL933791 0.72 CHRNA7 (0.36) CYP2C19CYP2D6SYKALDH1A1TSHR
SCHEMBL8486135 0.71 AOC3 (0.41) ALDH1A1LMNAMAPTCYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3072890-A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy MEI Pharma, Inc. (US) 2016-09-28 EP disclosed